EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Malignant Ovarian Germ Cell Tumor—Survival and Reproductive Outcomes and Patterns of Relapse

Sayak Dey, Srikant Anne, Sushmita Rath, Ravindra Nandhana, Seema Gulia iD, Biswajit Dash, Santosh Menon, Bharat Rekhi, Akshay Baheti, Nilesh Sable, Palak Popat, Sandeep Tandon und 13 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.71936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Sayak Dey und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant ovarian germ cell tumors [MOGCT] are rare cancers affecting young women and often present in advanced stages. This study aimed to evaluate their survival outcomes.

Methods

This is a retrospective study of patients diagnosed with MOGCT between 2013 to 2018. Clinicopathologic data were retrieved from electronic medical records. Survival analysis was done using the Kaplan – Meier method.

Results

A total of 170 patients were analyzed. The median age was 25 years (range: 15–68). Histological subtypes were dysgerminoma 37% (n‐63), yolk sac tumor 21% (n‐36), Immature teratoma 21% (n‐35), mixed germ cell tumor 17% (n‐29), and mature teratoma with somatic malignancy 4% (n‐7). Presentation in early stage (I and II) was 64% ( n = 108), while 36% ( n = 62) had advanced stage (Stage III/IV). Chemotherapy was received by 134 patients, of whom 49 received it in a neoadjuvant setting. Most patients ( n = 134–79%) underwent fertility‐sparing surgery, of whom 87% (117 of 134) resumed menstruation after completion of chemotherapy, with 18 successful pregnancies. Patients with relapsed yolk sac tumors (4) presented with ascites and peritoneal disease and could not be salvaged. Median follow‐up was 62 months [range 58–65 months]. The 5‐year progression‐free survival for stage I/II was 86% (95% CI 79–93) and for stage III/IV was 70% (95% CI 58–82). The 5‐year overall survival for stage I/II was 99% [95% CI 97–100] and for Stage III/IV was 88% (95% CI 79–97).

Conclusions

Patients presenting with advanced MOGCT can be offered fertility‐sparing surgery after neoadjuvant chemotherapy with no detriment in oncological outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsNeoplasms, Germ Cell and EmbryonalNeoplasm Recurrence, LocalHumansFemaleRetrospective StudiesAdultAdolescentYoung AdultMiddle AgedAgedNeoplasm StagingFertility PreservationPregnancy

Stichwörter der Autor:innen

malignant ovarian germ cell tumorneoadjuvant chemotherapypatterns of relapsereproductive outcomesurvival

Autor:innen und Institutionen

  • Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Division of Gynecologic Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Surgical Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Pulmonary Medicine, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Department of Biochemistry, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

ORCID-Profile: Seema Gulia, Amita Maheshwari, Jaya Ghosh, Sudeep Gupta

Zitieren

APA

Dey, S., Anne, S., Rath, S., Nandhana, R., Gulia, S., Dash, B., Menon, S., Rekhi, B., Baheti, A., Sable, N., Popat, P., Tandon, S., Ghosh, K., Gurram, L., Parab, S. S., Logkumer, A. N., Jhadhav, S., Chopra, S., Surappa, S. T., …, & Gupta, S. (2026). Malignant Ovarian Germ Cell Tumor—Survival and Reproductive Outcomes and Patterns of Relapse. Cancer Medicine. https://doi.org/10.1002/cam4.71936

Vancouver

Dey S, Anne S, Rath S, Nandhana R, Gulia S, Dash B, et al. Malignant Ovarian Germ Cell Tumor—Survival and Reproductive Outcomes and Patterns of Relapse. Cancer Medicine. 2026. doi:10.1002/cam4.71936

BibTeX
@article{Dey2026,
  author = {Dey, Sayak and Anne, Srikant and Rath, Sushmita and Nandhana, Ravindra and Gulia, Seema and Dash, Biswajit and Menon, Santosh and Rekhi, Bharat and Baheti, Akshay and Sable, Nilesh and Popat, Palak and Tandon, Sandeep and Ghosh, Kinjalka and Gurram, Lavanya and Parab, Sarika Shivram and Logkumer, Apenla N and Jhadhav, Sunita and Chopra, Supriya and Surappa, Shylasree T and Bansal, Vandana and Balsarkar, Geeta and Deodhar, Kedar and Maheshwari, Amita and Ghosh, Jaya and Gupta, Sudeep},
  title = {Malignant Ovarian Germ Cell Tumor—Survival and Reproductive Outcomes and Patterns of Relapse},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71936}
}
Kostenlos starten →